Cancer cell migration is an actomyosin-dependent process, consistent with the widespread effects of LPA on RHO GTPase signaling, actin and MLC2 (Fig. 5) with a major role for LPAR1 (Figs. 2 and 3). Here, MYL9 is linked to cancer.